InVivo Therapeutics Holdings Corp. (NVIV) today announced the appointment of Ann Merrifield to its Board of Directors. Ms. Merrifield most recently was President and Chief Executive Officer at PathoGenetix, a genomics company that developed and commercialized an automated system for rapid bacterial identification from complex samples.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
